DK1616184T3 - Fremgangsmåde og kit til at påvise tidlig begyndelse af renal tubulær cellebeskadigelse - Google Patents
Fremgangsmåde og kit til at påvise tidlig begyndelse af renal tubulær cellebeskadigelseInfo
- Publication number
- DK1616184T3 DK1616184T3 DK04758356T DK04758356T DK1616184T3 DK 1616184 T3 DK1616184 T3 DK 1616184T3 DK 04758356 T DK04758356 T DK 04758356T DK 04758356 T DK04758356 T DK 04758356T DK 1616184 T3 DK1616184 T3 DK 1616184T3
- Authority
- DK
- Denmark
- Prior art keywords
- ngal
- renal
- kit
- cell injury
- early onset
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45814303P | 2003-03-27 | 2003-03-27 | |
US48159603P | 2003-11-04 | 2003-11-04 | |
PCT/US2004/009191 WO2004088276A2 (en) | 2003-03-27 | 2004-03-26 | A method and kit for detecting the early onset of renal tubular cell injury |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1616184T3 true DK1616184T3 (da) | 2009-10-19 |
DK1616184T4 DK1616184T4 (da) | 2018-08-13 |
Family
ID=33135089
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10183320.0T DK2360475T3 (da) | 2003-03-27 | 2004-03-26 | Fremgangsmåde og kit til detektion af tidlig indtræden af renal tubulær celleskade |
DK04758356.2T DK1616184T4 (da) | 2003-03-27 | 2004-03-26 | Fremgangsmåde og kit til at påvise tidlig begyndelse af renal tubulær cellebeskadigelse |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10183320.0T DK2360475T3 (da) | 2003-03-27 | 2004-03-26 | Fremgangsmåde og kit til detektion af tidlig indtræden af renal tubulær celleskade |
Country Status (14)
Country | Link |
---|---|
US (11) | US20040219603A1 (da) |
EP (3) | EP2360475B1 (da) |
JP (2) | JP5392980B2 (da) |
CN (1) | CN102183656B (da) |
AT (1) | ATE437371T1 (da) |
AU (1) | AU2004225472B2 (da) |
BR (1) | BRPI0408802B8 (da) |
CA (1) | CA2520658A1 (da) |
DE (1) | DE602004022150D1 (da) |
DK (2) | DK2360475T3 (da) |
ES (3) | ES2330005T5 (da) |
MX (1) | MXPA05010385A (da) |
NZ (1) | NZ543028A (da) |
WO (1) | WO2004088276A2 (da) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03003281A (es) | 2000-10-13 | 2004-05-21 | Childrens Medical Center | Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos. |
DE602004022150D1 (de) * | 2003-03-27 | 2009-09-03 | Childrens Hosp Medical Center | Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung |
US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
CA2565701A1 (en) * | 2004-05-06 | 2005-11-17 | Jonathan M. Barasch | Ngal for reduction and amelioration of ischemic and nephrotoxic injuries |
ES2703434T3 (es) * | 2004-12-20 | 2019-03-08 | Antibodyshop As | Determinación de lipocalina asociada a gelatinasa de neutrófilos (NGAL) como marcador diagnóstico para trastornos renales |
US20080050832A1 (en) * | 2004-12-23 | 2008-02-28 | Buechler Kenneth F | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
US7858324B2 (en) * | 2005-02-18 | 2010-12-28 | Children's Medical Center Corporation | Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin |
US20070037232A1 (en) * | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
US20070087387A1 (en) | 2005-04-21 | 2007-04-19 | Prasad Devarajan | Method for the Early Detection of Renal Disease Using Proteomics |
JP2009510478A (ja) * | 2005-10-03 | 2009-03-12 | バイオサイト インコーポレイテッド | 全身性炎症反応症候群の診断および/または予後診断のための方法および組成物 |
US20080090304A1 (en) * | 2006-10-13 | 2008-04-17 | Barasch Jonathan Matthew | Diagnosis and monitoring of chronic renal disease using ngal |
US20100062537A1 (en) * | 2005-11-30 | 2010-03-11 | Harald Mischak | Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO) |
WO2007125385A2 (en) * | 2005-12-22 | 2007-11-08 | Neurochem (International) Limited | Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
CN101421622A (zh) | 2006-02-17 | 2009-04-29 | 儿童医学中心公司 | 作为癌症生物标志物的游离ngal |
US7662578B2 (en) | 2006-04-21 | 2010-02-16 | Children's Hospital Medical Center | Method and kit for the early detection of impaired renal status |
US20080090765A1 (en) * | 2006-05-25 | 2008-04-17 | The Trustees Of Columbia University In The City Of New York | Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage |
PL2035835T3 (pl) * | 2006-05-30 | 2012-05-31 | Antibodyshop As | Sposoby szybkiej oceny ciężkości urazu |
JP2010500535A (ja) * | 2006-08-07 | 2010-01-07 | アンチボディショップ・アクティーゼルスカブ | 重大な腎損傷を除外するための診断検査 |
GB0617429D0 (en) * | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
EP2095106B1 (en) * | 2006-11-14 | 2013-03-20 | Alere San Diego, Inc. | Methods and compositions for diagnosis and prognosis of renal artery stenosis |
EP2500723B1 (en) * | 2006-11-14 | 2015-07-08 | Alere San Diego, Inc. | Methods for monitoring and risk prediction in cardiorenal syndrome |
CN101730529A (zh) * | 2006-12-22 | 2010-06-09 | 贝鲁斯健康(国际)有限公司 | 用于治疗代谢疾病和糖尿病的方法、化合物和组合物 |
CN101680903A (zh) * | 2007-03-21 | 2010-03-24 | 比奥波托诊断股份公司 | 肾损伤的诊断试验 |
US20090004755A1 (en) * | 2007-03-23 | 2009-01-01 | Biosite, Incorporated | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
US8221995B2 (en) * | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
ES2532220T3 (es) * | 2007-03-26 | 2015-03-25 | Novartis Ag | Biomarcadores de seguridad renal predictiva y señales de biomarcadores para monitorizar la función renal |
US8846036B2 (en) | 2007-10-19 | 2014-09-30 | Abbott Laboratories | Antibodies that bind to mammalian NGAL and uses thereof |
WO2009059259A2 (en) * | 2007-10-31 | 2009-05-07 | Children's Hospital Medical Center | Detection of worsening renal disease in subjects with systemic lupus erythematosus |
PL2215481T5 (pl) † | 2007-11-15 | 2017-10-31 | Bioporto Diagnostics As | Zastosowanie diagnostyczne indywidualnych postaci cząsteczkowych biomarkera |
WO2009114699A2 (en) * | 2008-03-12 | 2009-09-17 | The Trustees Of Columbia University In The City Of New York | High molecular weight ngal as a biomarker for chronic kidney disease |
US20090239242A1 (en) * | 2008-03-18 | 2009-09-24 | Biotrin Intellectual Properties Limited | Method for the early identification and prediction of kidney injury |
US20090238812A1 (en) | 2008-03-18 | 2009-09-24 | Biotrin Intellectual Properties Limited | Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery |
US7977110B2 (en) * | 2008-06-02 | 2011-07-12 | Children's Hospital Medical Center | Method for distinguishing between kidney dysfunctions |
US20100122355A1 (en) * | 2008-07-16 | 2010-05-13 | Neal Paragas | Transgenic Reporter Mouse and Method for Use |
HUP0800448A2 (en) * | 2008-07-21 | 2011-02-28 | Pecsi Tudomanyegyetem | Diagnosis of systemic diseases |
US20120083421A1 (en) * | 2008-10-16 | 2012-04-05 | The Trustees Of Columbia University In The City Of New York | Use of urinary ngal to diagnose and monitor hiv-associated nephropathy (hivan) |
US20100105150A1 (en) * | 2008-10-24 | 2010-04-29 | Abbott Laboratories | Isolated human autoantibodies to neutrophil gelatinase-associated lipocalin (ngal) and methods and kits for the detection of human autoantibodies to ngal |
CA2742291A1 (en) * | 2008-11-05 | 2010-05-14 | Abbott Laboratories | Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, andmethods of enrichment, analysis and use |
US20110287964A1 (en) * | 2008-11-17 | 2011-11-24 | The Brigham And Women's Hospital, Inc. | Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans |
US9476880B2 (en) * | 2008-11-21 | 2016-10-25 | Future Medical Diagnostics Co., Ltd. | Methods, devices and kits for detecting or monitoring acute kidney injury |
ES2530574T3 (es) * | 2009-01-28 | 2015-03-03 | Ind Tech Res Inst | Biomarcadores asociados a la nefropatía |
US20100233740A1 (en) * | 2009-02-12 | 2010-09-16 | Jonathan Barasch | Use of urinary ngal to distinguish kidney disease and predict mortality in subjects with cirrhosis |
US20100233739A1 (en) * | 2009-02-12 | 2010-09-16 | Jonathan Barasch | Use of urinary ngal to diagnose unilateral and bilateral urinary obstruction |
WO2011000938A1 (de) * | 2009-07-02 | 2011-01-06 | Mosaiques Diagnostics And Therapeutics Ag | Verfahren und marker zur diagnose eines akuten nierenversagens |
US20120315649A1 (en) * | 2009-08-28 | 2012-12-13 | Astute Medical ,Inc. a corporation | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2011053832A1 (en) * | 2009-10-29 | 2011-05-05 | The Trustees Of Columbia University In The City Of New York | Use of urinary ngal to diagnose sepsis in very low birth weight infants |
AU2011269847A1 (en) | 2010-02-26 | 2013-01-31 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
US20110229921A1 (en) | 2010-03-18 | 2011-09-22 | Abbott Laboratories | METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
WO2011149962A1 (en) | 2010-05-24 | 2011-12-01 | The Trustees Of Columbia University In The City Of New York | Mutant ngal proteins and uses thereof |
CN103080743B (zh) * | 2010-06-23 | 2015-07-22 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断及预后的方法和组合物 |
NZ605698A (en) | 2010-06-23 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
WO2012068545A1 (en) * | 2010-11-18 | 2012-05-24 | Jonathan Barasch | Ngal in acute kidney injury |
NL2007112C2 (en) | 2011-07-14 | 2013-01-15 | Brainlabs B V | Novel diagnostic method for diagnosing depression and monitoring therapy effectiveness. |
US9387031B2 (en) * | 2011-07-29 | 2016-07-12 | Medtronic Ablation Frontiers Llc | Mesh-overlayed ablation and mapping device |
KR20140074307A (ko) * | 2011-08-26 | 2014-06-17 | 아스튜트 메디컬 인코포레이티드 | 신장 손상 및 신부전의 진단 및 예후진단을 위한 방법 및 조성물 |
WO2014081980A2 (en) | 2012-11-21 | 2014-05-30 | The Trustees Of Columbia University In The City Of New York | Mutant ngal proteins and uses thereof |
US10712349B2 (en) | 2014-04-15 | 2020-07-14 | The Brigham And Women's Hospital, Inc. | Circulating KIM-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney |
EP3577458A4 (en) | 2017-02-06 | 2021-04-07 | Astute Medical, Inc. | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PREDICTION OF RENAL LESION AND RENAL INSUFFICIENCY |
EP3736570A1 (en) | 2019-05-09 | 2020-11-11 | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | Method for the diagnosis, sub-classification and prognosis of acute kidney injury by detecting cct7 |
CN112076309A (zh) * | 2020-07-27 | 2020-12-15 | 南通大学 | 一种环状促红素衍生肽在肾损伤和环孢素a损伤保护中的应用 |
WO2022082013A1 (en) * | 2020-10-16 | 2022-04-21 | Lmx Medtech Llc | Method for correction for urine volume |
CN113083264A (zh) * | 2021-04-16 | 2021-07-09 | 郑州大学 | 二氧化硅-金属有机骨架核壳型复合材料及其在硫醇小分子检测方面的应用 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622871A (en) | 1987-04-27 | 1997-04-22 | Unilever Patent Holdings B.V. | Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents |
US3635091A (en) * | 1970-08-31 | 1972-01-18 | Frederick D Linzer | Midstream urine specimen and fractional fluid collectors |
IT1074038B (it) * | 1976-08-05 | 1985-04-17 | Simes | Esteri della epinina |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4357343A (en) * | 1981-06-26 | 1982-11-02 | Baxter Travenol Laboratories, Inc. | Nutritional composition for management of renal failure |
US4632901A (en) | 1984-05-11 | 1986-12-30 | Hybritech Incorporated | Method and apparatus for immunoassays |
US4731326A (en) * | 1984-06-04 | 1988-03-15 | Ortho Diagnostic Systems Inc. | Disease diagnosis by detection of shed normal tissue antigens |
US4640909A (en) * | 1985-05-07 | 1987-02-03 | J. T. Baker Chemical Company | Bonded phase of silica and carboalkoxyalkyl silanes for solid phase extraction |
IL85257A (en) * | 1987-02-10 | 1993-02-21 | Tanabe Seiyaku Co | Pharmaceutical compositions containing 2-(4-methoxyphenyl) 3-acetoxy-5-- (2-(dimethylamino) ethyl) -8-chloro-2,3- dihydro-1,5-benzothiazepin -4 (5h)-one having renal function-improving effect and diuretic effect |
US4900662A (en) * | 1987-07-21 | 1990-02-13 | International Immunoassay Laboratories, Inc. | CK-MM myocardial infarction immunoassay |
US4870007A (en) * | 1987-12-18 | 1989-09-26 | Eastman Kodak Company | Immobilized biotinylated receptor in test device, kit and method for determining a ligand |
US5273743A (en) | 1990-03-09 | 1993-12-28 | Hybritech Incorporated | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
JP2912413B2 (ja) * | 1990-03-28 | 1999-06-28 | 東亜医用電子株式会社 | 粒度分布作成方法 |
US5405832A (en) * | 1991-11-27 | 1995-04-11 | Immtech International Inc. | Method of treating non-streptococcal bacterial infections |
EP0575906A2 (en) * | 1992-06-19 | 1993-12-29 | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. | Sandwich immunoassay of beta-N-acetylglucosaminidase and monoclonal antibody used therein |
SE9401351D0 (sv) * | 1994-04-21 | 1994-04-21 | Venge | A method for diagnosis |
US6348571B1 (en) * | 1994-09-12 | 2002-02-19 | Northwestern University | Corticotropin release inhibiting factor and methods of using same |
US5552313A (en) * | 1994-11-21 | 1996-09-03 | Kansas University | DNA encoding mouse phosphotriesterase-related protein |
CA2233845A1 (en) * | 1995-10-02 | 1997-04-10 | Judah Weinberger | Biochemical markers of ischemia |
US5750345A (en) * | 1995-10-31 | 1998-05-12 | Evanston Hospital Corporation | Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders |
HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
US5627034A (en) * | 1995-12-05 | 1997-05-06 | Wisconsin Alumni Research Foundation | Assay for carcinoma proliferative status by measuring NGAL expression level |
DE69735364T3 (de) * | 1996-05-24 | 2010-05-06 | Biogen Idec Ma Inc., Cambridge | Modulatoren für die regenerierung von gewebe |
US5945294A (en) * | 1996-11-26 | 1999-08-31 | Heska Corporation | Method to detect IgE |
JP3334558B2 (ja) * | 1997-04-23 | 2002-10-15 | 富士レビオ株式会社 | 酵素免疫測定方法及び試験片 |
US6461827B1 (en) * | 1997-04-30 | 2002-10-08 | Mauha Corporation | Methods and kits for detecting or predicting ischemic disorders |
WO1999007740A2 (en) * | 1997-08-06 | 1999-02-18 | Zymogenetics, Inc. | Lipocalin homologs |
US6242246B1 (en) * | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
US6500627B1 (en) | 1998-02-03 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by HCG assay |
US6309888B1 (en) * | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
AUPP784398A0 (en) * | 1998-12-21 | 1999-01-21 | Monash University | Kidney disease detection and treatment |
US6114123A (en) * | 1999-06-14 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Lipocalin family protein |
AU5330200A (en) * | 1999-06-18 | 2001-01-09 | Michigan State University | Method and apparatus for the detection of volatile products in a sample |
US6762032B1 (en) * | 1999-08-23 | 2004-07-13 | Biocrystal, Ltd. | Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response |
US20020160495A1 (en) * | 2000-09-20 | 2002-10-31 | University Of Medicine And Dentistry | Soluble ischemia activated protein |
AU9396401A (en) * | 2000-10-03 | 2002-04-15 | Rowett Res Inst | Method of assaying pyrrole-containing biological compounds |
MXPA03003281A (es) * | 2000-10-13 | 2004-05-21 | Childrens Medical Center | Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos. |
US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
WO2002089657A2 (en) * | 2001-05-04 | 2002-11-14 | Biosite, Inc. | Diagnostic markers of acute coronary syndromes and methods of use thereof |
US20040203083A1 (en) * | 2001-04-13 | 2004-10-14 | Biosite, Inc. | Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases |
EP1390497A2 (en) * | 2001-05-25 | 2004-02-25 | Genset | Human cdnas and proteins and uses thereof |
US6847451B2 (en) * | 2002-05-01 | 2005-01-25 | Lifescan, Inc. | Apparatuses and methods for analyte concentration determination |
WO2004006941A1 (en) * | 2002-07-17 | 2004-01-22 | Index Pharmaceuticals Ab | Antisense compounds, methods and compositions for treating ngal-related inflammatory disorders |
CN1220487C (zh) * | 2003-03-26 | 2005-09-28 | 浙江大学 | 复方肾保护氨基酸组合物及其应用 |
DE602004022150D1 (de) * | 2003-03-27 | 2009-09-03 | Childrens Hosp Medical Center | Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung |
ES2703434T3 (es) * | 2004-12-20 | 2019-03-08 | Antibodyshop As | Determinación de lipocalina asociada a gelatinasa de neutrófilos (NGAL) como marcador diagnóstico para trastornos renales |
US7977110B2 (en) * | 2008-06-02 | 2011-07-12 | Children's Hospital Medical Center | Method for distinguishing between kidney dysfunctions |
-
2004
- 2004-03-26 DE DE602004022150T patent/DE602004022150D1/de not_active Expired - Lifetime
- 2004-03-26 BR BRPI0408802A patent/BRPI0408802B8/pt active IP Right Grant
- 2004-03-26 NZ NZ543028A patent/NZ543028A/en unknown
- 2004-03-26 DK DK10183320.0T patent/DK2360475T3/da active
- 2004-03-26 EP EP10183320.0A patent/EP2360475B1/en not_active Expired - Lifetime
- 2004-03-26 EP EP08169401.0A patent/EP2083270B1/en not_active Expired - Lifetime
- 2004-03-26 EP EP04758356.2A patent/EP1616184B2/en not_active Expired - Lifetime
- 2004-03-26 CN CN201110032921.2A patent/CN102183656B/zh not_active Expired - Lifetime
- 2004-03-26 AT AT04758356T patent/ATE437371T1/de not_active IP Right Cessation
- 2004-03-26 DK DK04758356.2T patent/DK1616184T4/da active
- 2004-03-26 US US10/811,130 patent/US20040219603A1/en not_active Abandoned
- 2004-03-26 WO PCT/US2004/009191 patent/WO2004088276A2/en active Application Filing
- 2004-03-26 ES ES04758356.2T patent/ES2330005T5/es not_active Expired - Lifetime
- 2004-03-26 CA CA002520658A patent/CA2520658A1/en not_active Abandoned
- 2004-03-26 ES ES08169401T patent/ES2739463T3/es not_active Expired - Lifetime
- 2004-03-26 AU AU2004225472A patent/AU2004225472B2/en not_active Expired
- 2004-03-26 JP JP2006509304A patent/JP5392980B2/ja not_active Expired - Lifetime
- 2004-03-26 ES ES10183320T patent/ES2754753T3/es not_active Expired - Lifetime
- 2004-03-26 MX MXPA05010385A patent/MXPA05010385A/es active IP Right Grant
-
2007
- 2007-06-28 US US11/770,422 patent/US20070254370A1/en not_active Abandoned
-
2008
- 2008-12-05 US US12/329,310 patent/US20090123941A1/en not_active Abandoned
-
2009
- 2009-02-09 US US12/367,897 patent/US20090181407A1/en not_active Abandoned
-
2010
- 2010-03-26 US US12/732,593 patent/US20100233728A1/en not_active Abandoned
- 2010-05-21 US US12/785,275 patent/US20100227418A1/en not_active Abandoned
-
2011
- 2011-06-21 JP JP2011137544A patent/JP2011221033A/ja active Pending
- 2011-10-12 US US13/271,588 patent/US20120028371A1/en not_active Abandoned
-
2013
- 2013-02-04 US US13/758,221 patent/US20130137191A1/en not_active Abandoned
- 2013-02-06 US US13/760,498 patent/US20130137116A1/en not_active Abandoned
- 2013-03-13 US US13/798,790 patent/US20130183693A1/en not_active Abandoned
-
2015
- 2015-03-16 US US14/658,685 patent/US20150185231A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1616184T3 (da) | Fremgangsmåde og kit til at påvise tidlig begyndelse af renal tubulær cellebeskadigelse | |
ATE488765T1 (de) | Verfahren zum frühen nachweis einer nierenkrankheit und -verletzung | |
AU2002902A (en) | Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker | |
WO2006073682A3 (en) | Diagnostic test | |
AU2002327308A1 (en) | Methods for evaluating pathologic conditions using extracellular rna | |
WO2006076025A3 (en) | Immune cell biosensors and methods of using same | |
WO2006116351A3 (en) | Method for the early detection of renal disease using proteomics | |
SE0400191D0 (sv) | A test kit for detecting periodontal disease | |
WO2001042502A3 (en) | Methods for disease detection | |
ATE490465T1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
WO2012017466A8 (en) | Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof | |
DE60129314D1 (de) | Diagnose von leberfibrose mit hilfe von serummarkeralgorithmen | |
ES2194116T3 (es) | Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona. | |
FR2816411B1 (fr) | Moyens de detection de la transformation pathologique de la proteine app et leurs applications | |
FR2806739B1 (fr) | Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation | |
EP1767652A4 (en) | GENMARKER AND ITS USE | |
ITMI20042473A1 (it) | Sistema per l'effettuazione di verifiche rapide durante la configurazione delle celle di riferimento flash | |
BRPI0512655A (pt) | bioexame de rna | |
ATE433991T1 (de) | Morbus-crohn-antikörperepitoppeptid und reagens zum testen auf morbus crohn | |
BR0308095A (pt) | Teste para anticorpos anti-ingap | |
WO2005115394A3 (en) | Prenyl-electrostatic switch, and methods of use | |
EA199800959A1 (ru) | ПРИМЕНЕНИЕ ГЕНЕТИЧЕСКОЙ МОДИФИКАЦИИ В ГЕНЕ b3- СУБЪЕДИНИЦЫ ЧЕЛОВЕЧЕСКОГО G-ПРОТЕИНА ДЛЯ ДИАГНОСТИКИ ЗАБОЛЕВАНИЙ | |
Porcher et al. | Biological markers as indicators of exposure and pneumoconiotic risk: prospective study | |
DE60115453D1 (de) | Verfahren zur detektion der apoptose durch ermittlung von cytochrom c als apoptosespezifischem marker, der durch zelluläre ausschüttungsvorgänge ins extrazelluläre medium abgegeben wird | |
WO2006046250A3 (en) | Compositions and methods for diagnosing and treating insulin resistance |